Publication | Open Access

Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial

Cog Anbl1221Neuro-oncologyGliomaMedicineNeurologyOncologyRadiation Oncology